About Comms

This author has not yet filled in any details.
So far Comms has created 401 blog entries.

INFANT Biobanking Manager wins NSAI Award

By |2020-11-22T12:48:10+00:00October 28th, 2018|

Wednesday 24 October 2018

Emma Snapes, INFANT’s Biobanking Manager received the National Standards Authority of Ireland award at the NSAI Annual Standards Forum in Dublin. The award was in recognition of Emma’s exceptional dedication to standards development.

Emma is the Irish academic representative and International Expert to ISO TC276 for Biotechnology and was instrumental in the development of ISO 20387 (2018): EN, the first dedicated biobanking standard.

Emma is continuing her work with ISO TC276 and is currently working on a technical report that will accompany the biobanking standard to help interpret the requirements for each unique set up.

“I would likely to sincerely thank all the many individuals too numerous to mention in helping promote the Irish biobanking voice and in particular its expression in the horizontal biobanking standard. Encouragingly, this voice was one I often heard echoed back from other countries experts. It is my hope that those who undertake to fulfil the requirements laid out in the standard will realise the value in resultant high quality, reproducible results and timely achievement of research goals. Special thanks to my biobanking colleague and dear friend, Dr Aisling Doyle, who accompanied me to the award ceremony in Dublin. Aisling and I work closely together and together provide constant round the clock support for INFANT’s biobanking concerns. I remain ever grateful to INFANT directorship and UCC management for enabling her to partake in standards creation”.

Well done Emma!

INFANT Statement – Thank You

By |2020-11-22T12:48:26+00:00October 22nd, 2018|

Monday 22 October 2018

INFANT research matters

 

A huge thanks to everyone who contacted us or campaigned to raise awareness about INFANT over the last few weeks. Your generosity and support is extraordinary and we are immensely grateful. We want you to know that the INFANT team is determined to continue delivering high impact and vitally important research for the benefit of women and children in Ireland and worldwide.

 

Geraldine Boylan

Director, INFANT Research Centre

Doctor with parents and toddlerINFANT will continue delivering high impact and vitally important research

New Research: The Impact of Caesarean Section and the Risk of Childhood Obesity

By |2020-11-22T12:48:43+00:00October 11th, 2018|

Thursday 11 October 2018

New Research by INFANT PhD candidate, Gwinyai Masukume has been published in Scientific Reports.

The work is exploring the association between Caesarean Section (CS) and childhood obesity. Childhood obesity has been linked to CS via lack of exposure to vaginal microflora although the literature is inconsistent. The team investigated the association between CS birth and the risk of childhood obesity using the nationally representative Growing-Up-in-Ireland (GUI) cohort.

Toddler girlThere was insufficient evidence to support the link between CS and childhood obesity.

The study recruited 11134 infants. The exposure was categorised into normal vaginal birth (VD) [reference], assisted VD, elective (planned) CS and emergency (unplanned) CS.

After further analysis of the infants weight and height the team found insufficient evidence to support a causal relationship between elective CS and childhood obesity.

FULL PAPER HERE: https://www.nature.com/articles/s41598-018-33482-z

INFANT partners Incerb Acquired by US Medtech Firm

By |2020-11-22T12:48:58+00:00October 10th, 2018|

Wednesday 10 October 2018

Our research partners, Incereb Ltd, manufacturer of the neon neonatal EEG electrode array, have been aquired by Lifelines Neurodiagnostic Systems, Inc., provider of neurodiagnostic equipment and services.

Simon Griffin, CEO of Lifelines, noted, “We have been working with Incereb for several years in the US market, and their neon product is a perfect fit with our technology and growth plans. We are very excited not only to work with Jim Roche and Incereb on new product development but also with the INFANT Centre at University College Cork and the fantastic research being performed there under the stewardship of Professor Geraldine Boylan.”

Jim Roche, CEO of Incereb, noted “We have worked with Professor Geraldine Boylan since the formation of Incereb, and as an industry partner in INFANT. With LIfelines as our partners, and with their technology fitting seamlessly with Incerebs technology, we are now able to offer a complete EEG monitoring solution for the ICU”.

IncerebCongratulations to Incereb

Incereb will remain operating in Dublin as a subsidiary of the Lifelines group of companies. Plans are to increase R&D spending on a new product pipeline and grow the business by developing new markets and product lines.

“This is a perfect fit for Incereb in terms of our product offering and Lifelines’ sales and distribution network,” says Incereb CEO, Jim Roche, of the acquisition. Incereb has been working with Lifelines since 2015 to distribute Incereb in the US, and more recently worldwide.

“Declan O’Mahoney, Incereb director, has worked tirelessly with the management team consisting of Simon Forsyth, Paul Phillips, and me to get Incereb to this next stage of its evolution,” says Roche. “We are delighted with this acquisition and look forward to growing our business and product range together to bring neonatal and intensive care neuroprotective monitoring to the next level.”

Related Links

Rachel Williamson wins Young Investigator Award at ISSHP Conference

By |2020-11-22T12:49:13+00:00October 8th, 2018|

Monday 08 October 2018

Our PhD researcher, Rachel Williamson, won a Young Investigator Award from the Preeclampsia Foundation at the ISSHP European Conference in Amsterdam.

 

Eleni Tsiagas of the Preeclampsia Foundation and Rachel Williamson, winner of the Young Investigator Award, ISSHP 2018

 

 

Rachel’s presentation at the conference is entitled Investigating the Therapeutic Effects of L-Ergothionine As A Treatment for Pre-eclampsia 

Abstract:

Pre-eclampsia is proposed to result from placental ischemia, explosing the placenta to elevated levels of oxidative stress. L-Ergothionine is a natural water-soluble compound derived from histidine and is a physiological antioxidant due to its preferential concentration in high oxidative stress organs. L- Ergothionine has been shown to possess antioxidant, cytoprotective and anti-inflammatory effects, establishing its potential as a treatment for preeclampsia.

Objectives: To investigate the therapeutic effects of L- Ergothionine as a treatment for preeclampsia using the in-vivo reduced uterine perfusion pressure (RUPP) rat model.

Methods: L- Ergothionine (25mg/kg/day) was administered on gestational day 11 (GD11). RUPP was induced by placing silver clips on the abdominal aorta and the ovarian arteries on GD14. Mean arterial blood pressure (MABP) and vascular function were measured in all four groups. Pup and placental weights were also measured. Data is presented using the mean ± SD.

Results: L- Ergothionine reduced MABP in the group compaed to RUPP controls (134 mmHg  143 mmHg). There was a significant reduction in pup weight in RUPP control group compared to sham controls (1.802± 0.07 v 2.245 ± 0.06, P>0.0001). L- Ergothionine resuced fetal growth restriction in the RUPP group compared with the RUPP control group (2.048 ± 0.09 v 1.802 ± 0.07, P=0.05). Mesenteric arteries from the RUPP control group displayed impaired vasorelaxation, however pre-treatment with L- Ergothionine ameliorated this endothelial dysfunction.

Conclusion: Pre-treatment with L- Ergothionine in the RUPP model mediated some of the pathophysiological characteristics of pre-eclampsia, therefore, highlighting its potential as a treatment for pre-eclampsia.

 

INFANT Will Continue To Lead Important Research

By |2020-11-22T12:49:28+00:00October 2nd, 2018|

Tuesday 02 October 2018

As published in the Irish Examiner: 

 

Prof Geraldine Boylan, INFANT co-founder and director, and Professor of Neurophysiology at UCC, says it is vital to continue research into maternal and child health.

INFANT is Ireland’s only dedicated research centre spanning maternal and child health and has been recognised internationally as a world-leading organisation that is responsible for a number of research breakthroughs and life-saving science for mothers and babies.

NICU comfort holdingAs director, I am very proud to lead this important research centre.

We have made ground-breaking discoveries in neonatal seizure detection, pre-eclampsia, neonatal brain injury, maternal nutrition, and childhood allergy. INFANT has been at the heart of perinatal research and innovation for more than five years.

Funding from Science Foundation Ireland in 2013 was catalytic to the success of the INFANT Centre, and once  it was established, it was quickly recognised as a global force for development in perinatal healthcare and research.

Competitive research grants, collaboration requests and philanthropic funding from national and international sources supplemented the initial €6 million in start-up funding to grow to its €30 million portfolio today.

 

Prof Geraldine Boylan, INFANT Director 

 

Over the last five years, the INFANT Centre has been a high performing SFI research centre and it will continue working in this important area. INFANT is maturing and has a new ambitious programme that will build on the investment and success to date. This will require even more diversity of funding than before but the centre is confident of realising the initial vision of building an Institute of Maternal and Child Health of scale, impact and international.

For example, a number of new large-scale research programmes have been announced this Summer. INFANT is a lead partner in the Connect4Children network in Ireland, a European consortium developing paediatric clinical trials around the world which has one of the largest funding budgets (€140 million) awarded through the EU Innovative Medicines Initiative 2.

There is excellent paediatric research ongoing all over Ireland and the paediatric clinical trial infrastructure being built across Ireland will enable INFANT and its partners to access future funding to develop and test medicines specifically for children and infants.

Up to now, children and infants generally receive ‘smaller doses’ or a dilution of adult medicine rather than specifically designed treatments. One of INFANT’s key goals is to support the use of innovative trial designs and new quantitative methods to foster the development of paediatric medicines and to support research in rare paediatric diseases and high medical need areas.

INFANT is the only national research centre of scale working across the continuum of pregnant women, babies and young children.

pregnant lady sittingINFANT is the only national research centre of scale working across the continuum of pregnant women, babies and young children.

INFANT as a clinical and translational centre must combine basic and applied research on real unmet clinical needs with a drive to bring innovations and solutions to these clinical problems to the market.

We do this by working with a wide range of stakeholders and funders — clinicians, scientists, engineers, industry, government, funding agencies, donors and patients.

We will continue to collaborate with these partners — local, national and international.

UCC is committed to ensuring that INFANT continues to grow, flourish and deliver on the tremendous impact it can bring to science and society. Ireland and Cork in particular has a unique competitive advantage for research and innovation in perinatal health.

The INFANT Centre continues to be committed to scientific excellence and impactful research. We will continue to work directly with many funders, collaborators and philanthropists and their foundations on this lifesaving and life-changing work in the area of neonatal and maternal care. We look forward to the continued collaboration with families who are the cornerstone of this effort.

As director, I am very proud to lead this important research centre. We are indebted to the wonderful families who take part in our research and I am very proud of the community of researchers and staff in INFANT who are so committed to making things better for mothers and babies around the world.

INFANT Statement – SFI Funding

By |2020-11-22T12:49:52+00:00October 1st, 2018|

Monday 01 October 2018

Following an SFI Research Centre programme call for funding, the new proposal of the INFANT Centre at UCC has not been funded at this time but instead has been recommended to proceed to a national open call in 2020. The Centre opened in 2013 with initial funding from Science Foundation Ireland, which will end in May 2019. INFANT will continue its research work funded by a diverse range of national and international funding agencies, industry partners and philanthropic donors.

INFANT’s mission is to improve health outcomes for mothers and babies by focusing on clinical and health research and innovation in pregnancy, birth and early childhood. The Centre has grown rapidly from its initial award of €6M to over €30M in five years comprising donations, competitive funding awards, and global partnerships with industry and academic researchers which  has enabled the development of INFANT to the point where it now has over 100 staff, a dedicated paediatric clinical research unit, an internationally recognised biobank, a world-leading data hub and other clinical research infrastructure in obstetrics and neonatology.

The support from SFI for the Centre has, to date, been a significant catalyst for major growth and development. It has allowed INFANT to develop breakthroughs in seizure detection and in areas such as pre-eclampsia diagnosis, maternal and new-born nutrition and allergy. The Centre will continue to develop these areas and support maternal and child health research and innovation in its next phase for the benefit of mums, babies and children in Ireland and worldwide.

Pregnant Mum with DaughterWe will continue our research and innovation in its next phase for the benefit of mums, babies, and children in Ireland and worldwide.

INFANT Welcomes New PI, Prof Rhodri Cusack

By |2020-11-22T12:50:08+00:00September 24th, 2018|

Monday 24 September 2018

 

Rhodri Cusack is the Thomas Mitchell Professor of Cognitive Neuroscience in Trinity College Dublin, and a world-renowned expert in his field. Prof Geraldine Boylan, Director of the INFANT Centre noted that “The appointment of Prof Cusack as an INFANT PI is very exciting, it expands the impact INFANT will have, and will enable us to gain even more momentum as a world-leading research centre, improving health outcomes for babies around the world”.

The Vice President for Research and Innovation at UCC, Professor Anita Maguire welcomed the addition of this talented research leader to the INFANT Research Centre, noting that “Prof Cusack brings research expertise which is entirely complementary to the current expertise within INFANT, and as a result his addition will open exiting new research opportunities with potential to contribute to improved health outcomes”.

 

dad with sleeping babyHow does perinatal brain injury affect development?

Prof Cusack is the Thomas Mitchell Professor of Cognitive Neuroscience and head of the Cusack Lab in the Trinity College Institute of Neuroscience. As a graduate of Cambridge and the University of Birmingham, he has worked in the MRC Cognition and Brain Sciences Unit in Cambridge and more recently was Associate Professor at the Brain and Mind Institute of the University of Western Ontario. His research has been funded by the IRC, MRC, Wellcome Trust, BBSRC, EPSRC, CIHR, and NSERC. Rhodri has recently received a prestigious ERC Advanced Grant to explore neuroimaging and early infant brain development and has already started active research collaborations with INFANT in this area.

 

He and his team study the brain development of infants in their first year, a period in which many cognitive functions develop remarkably quickly. They also study how perinatal brain injury affects development and how some infants manage to be so resilient. Their research uses neuroimaging to predict the functional consequences of brain injury at an earlier age, as current behavioural and neurological tools are poor predictors of later impairments, which place stress on families and preclude earlier and more effective interventions. Prof Cusack’s team use a diverse set of neuroimaging methods. With magnetic resonance imaging (MRI) they study brain networks (using diffusion-weighted imaging, functional connectivity) and the developing responses to what an infant sees and hears (using functional MRI). They study infant behaviour and have pioneered ways to do large-scale testing online, and have developed many new tools that bring together computational models of cognition with new neuroimaging techniques, to answer the many fascinating and important questions concerning the origin of our minds. Prof. Cusack’s work and that of INFANT are well aligned strategically and this announcement highlights a formalising of current interactions.

We look forward to working with Rhodri, and warmly welcome him to the team.

INFANT Research Honoured With Collector’s Stamp from AnPost

By |2020-11-22T12:50:24+00:00September 5th, 2018|

Wednesday 05 September 2018

An Post unveiled four €1 stamps on Wed 5 September titled “Irish Scientific Discoveries” at the international Schrodinger at 75 Conference in the National Concert Hall. The series of stamps highlight recent scientific discoveries made by scientists who work in pioneering research and development in Ireland.

The science-based stamps represent new areas of research, which are generating new knowledge, cutting-edge technology, and competitive enterprise. The four topics are examples of innovative and impactful academic research being carried out in academic institutions around the country: these are new forms of light, fighting superbugs, emissions adsorption, and INFANT’s seizure prediction algorithm.

 

 

Created by An Post in partnership with Science Foundation Ireland, the Irish Scientific Discovery stamps feed into Ireland’s rich scientific history, recognising its growing reputation for scientific excellence worldwide.  This standing is evidenced by Ireland’s ascent in global ranking of scientific citations – now the 10th most innovative country in the world (Global Innovation Index) and 11th for overall IMD World Competitive Ranking, 2017. A 2016 report into Opportunities and Challenges for European Tech Employers also showed 29% of Ireland’s population are now employed in science and technology.

Launch Photo

Science Foundation Ireland– an agency of the Department of Business, Enterprise and Innovation – is the national foundation for investment in scientific and engineering research and contributes to societal and economic awareness of the value of science, technology, engineering and maths to our economy and society. Science Foundation Ireland were involved in the selection of scientific breakthroughs which feature on the stamps.

Speaking at the launch of the stamps at the Schrodinger at 75 conference, Professor Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland, said: ‘I am delighted to launch the stamp series dedicated to science in Ireland with An Post today. The release of the stamps comes at a fitting time, coinciding with the prestigious Schrodinger at 75 conference which welcomes Nobel Laureates and top researchers from around the world to Dublin. It is great to see our scientific achievements as a country being celebrated, as it is important to acknowledge our impact to date and to inspire our future work. This collection aims to showcase the excellent science and technology research ongoing across the country and encourages people to engage with it. The selected case studies represent just one small facet of the superb and wide-ranging contributions that Irish scientists are making to international advancements in STEM.’

The scientific discoveries featured on the stamps are a credit to the institutions from which this new and exciting work is coming, they recognise the teams and individuals who are applying their minds and their experience to new discoveries and they show the importance of scientific investment and research in shaping the future.   The stamps are designed by Dublin based design agency, Detail, and are available in the GPO, Dublin, at selected post offices nationwide or online at www.irishstamps.ie

Related Links

UCC Paediatric Academic Unit Opens

By |2020-11-22T12:50:40+00:00June 22nd, 2018|

Friday 22 June 2018

MINISTER COVENEY OPENS NEW €5MILLION UCC PAEDIATRIC ACADEMIC UNIT

 

Ireland’s first integrated paediatric academic unit was officially opened on Monday 18th June by Minister for Foreign Affairs Simon Coveney, T.D. Following a multi-million euro investment by University College Cork, Science Foundation Ireland, and a generous philanthropic donation, the new unit is located in an exceptional tri-location between Cork University Hospital, Cork University Maternity Hospital, and University College Cork.

The first of its kind in Ireland, the new paediatric academic unit focuses on improving health outcomes for children, from infancy through to adolescence through teaching, research, and innovation. Home to more than 60 staff, including clinical and academic leaders, scientists, nursing staff and PhD researchers; the academic teams tackle clinical problems such as newborn brain injury, infant seizures, allergy, eczema, sleep, and explore ways of enhancing the long-term wellbeing and development of children.

Ella & SimonCollaboration between clinicians, scientists and families is at the heart of the unit

Speaking at the official opening, Tánaiste Simon Coveney T.D. said, “This is a progressive and innovative step to improving children’s health in Ireland and internationally through academic research. The collaboration between clinicians, researchers, industry, trainees, patients and their families will yield enormously positive results to shape paediatric healthcare of the future. I would like to acknowledge the vision of UCC and the College of Medicine and Health in leading this development with the SFI funded INFANT Centre. The funding model for this initiative should also be lauded which has allowed significant exchequer funds via SFI and philanthropy to leverage substantial support from UCC to realise the overall investment required. ”

The new unit has a substantial footprint of 1400M2 covering 32 rooms, including state of the art assessment rooms for clinical studies, seminar rooms, clinical skills rooms, tutorial rooms, offices and laboratory spaces. The unit is the new home for both Paediatric Academic training and the paediatric clinical research arm of the world leading SFI-funded INFANT Centre. The unit will facilitate a range of clinical research programmes that will improve children’s health and support the exploration and development of new innovations by industry.

President of UCC, Patrick O’Shea noted “UCC is proud to invest in this facility as it will provide world-class teaching and research with real impact. The facility is now home to one of the leading paediatric research departments in Ireland and the clinical research of INFANT, a world-leading SFI Research Centre, which will support long-term sustainable and impactful research, talent development, and training for children’s research”.

Minister & Massage ClassTomorrow’s doctors will see research-led healthcare being developed and delivered

Professor of Paediatrics and Child Health, Jonathan Hourihane noted, “This facility in the School of Medicine is integrated with the Cork University Hospital paediatric outpatient departments on the floor below. This will allow tomorrow’s doctors to see research-led healthcare being developed and delivered and will make patient research more understandable and accessible for children”.

“The development of clinical research infrastructure and research studies for children and infants is absolutely vital and will result in better outcomes for Irish children. Recruitment and retention of patients to clinical studies here in Cork leads the way in Europe. We are incredibly grateful to the Irish families who participate in our research and would like to take this opportunity to thank them sincerely for their dedication and support.” said Geraldine Boylan, Co-Founder and Director of the INFANT Research Centre and UCC Professor of Neonatal Physiology. “We would also like to sincerely acknowledge the support of the College of Medicine & Health, UCC Central Research Support Services for all of their assistance and ongoing support, and our colleagues in the Clinical Research Facility-Cork”.

Go to Top